ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

DNLI Denali Therapeutics Inc

24.68
0.18 (0.73%)
27 Nov 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 42.14M52.48M3.56M10.28M35.14M000
Operating Income -66.5M-61.42M-107.49M-105.34M-120.82M-132.57M-132.25M-116.59M
Pre Tax Income -65.22M-58.77M-103.3M-98.68M-109.78M-119.44M-101.8M-99.03M
Net Income -65.22M-58.79M-103.3M-98.68M-109.78M-119.47M-101.8M-99.03M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -66.5M-61.42M-107.49M-105.34M-120.82M-132.57M-117.72M-116.59M
EBITDA -64.42M-59.34M-105.35M-101.25M-110.77M-130.4M-130.09M-114.65M
Year End 31 December 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00129.16M26.68M335.66M48.66M108.46M330.53M
Operating Income -87.43M-90.14M-46.37M-213.18M62.72M-295.75M-340.74M-196.7M
Pre Tax Income -86.65M-88.19M-36.64M-197.97M71.96M-291.16M-325.97M-145.19M
Net Income -86.65M-88.19M-36.64M-197.61M71.14M-290.58M-325.99M-145.22M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -10.079-1.008-0.387-2.0540.59-2.376-2.398-1.051
EBIT -87.43M-90.14M-46.37M-213.18M62.72M-295.75M-340.74M-196.7M
EBITDA -85.93M-87.06M-38.96M-205.19M71.25M-287.15M-330.36M-179.97M